Publication withdrawn by sponsor
Sponsors
UCB Pharma, Universitair Medisch Centrum Utrecht, Astra Zeneca, Publication withdrawn by sponsor, Regeneron Pharmaceuticals, Inc.
Conditions
Publication withdrawn by sponsorRecurrent Ovarian Cancer / Ovarian Canceratopische dermatitis
Publication withdrawn by sponsorgewichtnon small cell lung cancer
lung tumor
Phase 1
Phase 2
Trial NL80852.028.22
RecruitingNL-OMON53829
Start: 2023-04-12Target: 18Updated: 2024-04-01
Trial : NL83392.078.23
Active, not recruitingNL-OMON53922
Start: 2024-04-22Target: 21Updated: 2024-12-09
Trial NL77181.056.21
RecruitingNL-OMON54050
Start: 2022-04-20Target: 10Updated: 2024-04-01
Trial NL-005412
NL-OMON57095
Start: 2024-10-31Target: 1000Updated: 2026-09-07
Trial NL87938.000.24
Active, not recruitingNL-OMON57341
Start: 2025-04-01Target: 74Updated: 2025-04-14
Phase 3
Unknown Phase
Trial NL77761.056.21
Active, not recruitingNL-OMON51945
Start: 2022-03-31Target: 24Updated: 2024-06-18
Trial NL81440.028.22
RecruitingNL-OMON53488
Start: 2023-07-17Target: 15Updated: 2024-04-01
Trial NL-005018
RecruitingNL-OMON53228
Start: 2024-03-01Target: 75Updated: 2026-09-07
Trial NL-005557
RecruitingNL-OMON57058
Start: 2024-09-26Target: 280Updated: 2026-09-07
Trial NL-000149
RecruitingNL-OMON57595
Start: 2025-04-15Target: 100Updated: 2026-09-07
Trial NL-009254
Active, not recruitingNL-OMON57734
Start: 2025-06-01Target: 14Updated: 2026-09-07
Trial NL-010143
Active, not recruitingNL-OMON57958
Start: 2025-11-02Target: 40Updated: 2026-09-07